Insulin lispro

Drug ingredient

CAS 133107-64-9

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 133107-64-9
US productionNot reported
Import value, 2024$16.4B
Top sourceIreland 94%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293719 · basket

These shares come from HS customs code 293719, which covers 53 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IE 94%IrelandAR 4%ArgentinaCN 1%ChinaDK 1%Denmark
7 FDA-registered drug labelers
A-S Medication Solutions
Eli Lilly and Company
Eli Lilly Italia SPA
Lilly del Caribe, Inc.
Lilly France
REMEDYREPACK INC.
Sanofi-Aventis U.S. LLC

Why It Matters

Sectors
Health
Downstream Uses

Appears in 16 drug and cosmetic product listings (FDA).

  • •Humalog
  • •Lyumjev
  • •Lyumjev KwikPen
  • •Insulin Lispro KwikPen
  • •Humalog KwikPen
  • •Insulin Lispro
  • •Admelog
  • •Lyumjev Tempo Pen
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Insulin Lispro-aabc Injection

    Shortage listed since October 24, 2025

  • to be discontinued

    Insulin Lispro Injection

    Shortage listed since October 24, 2025

See all current drug shortages

Chemical Identity

CAS133107-64-9
PubChem CID16132438
DTXSIDDTXSID90157956
FormulaC257H389N65O77S6
Mol. Weight5814 g/mol
SMILESCCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)CN.CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CS)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC6=CN=CN6)NC(=O)C(CO)NC(=O)CNC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(CC7=CN=CN7)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC8=CC=CC=C8)N

Data Sources

Brief citations

Insulin lispro (CAS 133107-64-9) https://chemicalindependence.com/chemical/133107-64-9/ PubChem: 16132438. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16132438 FDA National Drug Code directory: CAS 133107-64-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 133107-64-9. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293719 for CAS 133107-64-9. Reporting year: 2024. https://usatrade.census.gov/